Barely Significant
← all excerpts

Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022.

Br J Clin Pharmacol · 2025 · PMC11671323 · PMID 39224963

1
hedged sentence
closest p
boldest claim

The sentences

a clear trendno p-value reported
31 However, in this utilization study there was a clear trend of increased prescribing of SGLT2i and GLP‐1 RA by primary care providers, demonstrating some diffusion of updated guideline recommendations into primary care practice.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.